Blueprint Medicines Corp (NAS:BPMC)
$ 102.81 0.42 (0.41%) Market Cap: 6.44 Bil Enterprise Value: 6.09 Bil PE Ratio: 0 PB Ratio: 20.73 GF Score: 72/100

Blueprint Medicines Corp Annual Shareholders Meeting Transcript

Jun 02, 2021 / 08:00PM GMT
Release Date Price: $87.13 (-2.28%)
Jeffrey W. Albers
Blueprint Medicines Corporation - Chairman of the Board, CEO & President

Good afternoon, ladies and gentlemen. It's a pleasure to welcome you to the 2021 Annual Meeting of Stockholders, which is being held virtually this year via the Internet. I'm Jeff Albers, President and Chief Executive Officer of Blueprint Medicines, and I'll serve as Chair of this meeting. Tracey McCain, our Executive Vice President and Chief Legal Officer, will serve as Secretary and guide us through the proceedings today.

With that, I now call the meeting to order and will hand it over to Tracey to conduct the formal business of the meeting. Tracey?

Tracey L. McCain
Blueprint Medicines Corporation - Executive VP, Chief Legal Officer, Chief Compliance officer & Secretary

Thanks, Jeff. The business for this meeting is described in the notice of 2021 Annual Meeting of Stockholders of Blueprint Medicines Corporation. Please note that this meeting is being recorded. However, no one attending via the webcast or telephone is permitted to use any audio

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot